Characterization of Two Novel AmpC Beta-Lactamases from the Emerging Opportunistic Pathogen,

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2023 Feb 25

PMID 36830129

Authors

Stephen M Sharkady

Brandon Bailey

Dorothea K Thompson

Affiliations

Soon will be listed here.

Abstract

The genus (family ) causes a wide spectrum of acute infections in immunocompromised hosts, from pneumonia and bacteremia to oral ulcers and dialysis-related peritonitis. While infections are reported infrequently in the literature, documented clinical cases of this emerging opportunistic human pathogen have occurred worldwide. has clinical significance and exhibits antimicrobial drug resistance. However, little is known about the molecular basis underlying the resistance phenotypes in . We previously hypothesized that the open-reading frame in the SSMD04 genome encodes a chromosomal Ambler class C (AmpC) β-lactamase based on sequence homology. In this study, recombinant polyhistidine-tagged proteins were created by cloning the putative genes from SSMD04 and ATCC 33855 (a clinical isolate) into the pET-6xHN expression vector, overexpressing the proteins, and then purifying the recombinant AmpCs (rAmpCs) using immobilized metal affinity chromatography (Ni-NTA). The in vitro enzymatic analysis of the purified rAmpCs was performed to determine the and for various β-lactam substrates. The rAmpCs are functional class C β-lactamases when assayed using the chromogenic β-lactamase substrate, nitrocefin. The presence of functional AmpCs in both strains underscores the necessity of performing antibiotic susceptibility testing in the management of infections.

References

Walker J . The bicinchoninic acid (BCA) assay for protein quantitation. Methods Mol Biol. 1994; 32:5-8. DOI: 10.1385/0-89603-268-X:5. View

Joris B, Ghuysen J, Dive G, Renard A, Dideberg O, Charlier P . The active-site-serine penicillin-recognizing enzymes as members of the Streptomyces R61 DD-peptidase family. Biochem J. 1988; 250(2):313-24. PMC: 1148858. DOI: 10.1042/bj2500313. View

Sawa T, Kooguchi K, Moriyama K . Molecular diversity of extended-spectrum β-lactamases and carbapenemases, and antimicrobial resistance. J Intensive Care. 2020; 8:13. PMC: 6988205. DOI: 10.1186/s40560-020-0429-6. View

Aguilera A, Pascual J, Loza E, Lopez J, Garcia G, Liano F . Bacteraemia with Cedecea neteri in a patient with systemic lupus erythematosus. Postgrad Med J. 1995; 71(833):179-80. PMC: 2398165. DOI: 10.1136/pgmj.71.833.179. View

Matagne A, Lamotte-Brasseur J, Frere J . Catalytic properties of class A beta-lactamases: efficiency and diversity. Biochem J. 1998; 330 ( Pt 2):581-98. PMC: 1219177. DOI: 10.1042/bj3300581. View

Hugonnet J, Blanchard J . Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate. Biochemistry. 2007; 46(43):11998-2004. PMC: 2593862. DOI: 10.1021/bi701506h. View

Gudeta D, Pollini S, Docquier J, Bortolaia V, Rossolini G, Guardabassi L . Biochemical Characterization of CPS-1, a Subclass B3 Metallo-β-Lactamase from a Chryseobacterium piscium Soil Isolate. Antimicrob Agents Chemother. 2015; 60(3):1869-73. PMC: 4775976. DOI: 10.1128/AAC.01924-15. View

Jacoby G, Medeiros A . More extended-spectrum beta-lactamases. Antimicrob Agents Chemother. 1991; 35(9):1697-704. PMC: 245253. DOI: 10.1128/AAC.35.9.1697. View

Faheem M, Rehman M, Danishuddin M, Khan A . Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor. PLoS One. 2013; 8(2):e56926. PMC: 3578935. DOI: 10.1371/journal.pone.0056926. View

10.

Chan K, Tan K, Yin W, Tan J . Complete Genome Sequence of Cedecea neteri Strain SSMD04, a Bacterium Isolated from Pickled Mackerel Sashimi. Genome Announc. 2014; 2(6). PMC: 4271172. DOI: 10.1128/genomeA.01339-14. View

11.

Mohamudha Parveen R, Harish B, Parija S . Ampc Beta lactamases among gram negative clinical isolates from a tertiary hospital, South India. Braz J Microbiol. 2013; 41(3):596-602. PMC: 3768642. DOI: 10.1590/S1517-83822010000300009. View

12.

Ahmad H, Masroor T, Parmar S, Panigrahi D . Urinary tract infection by a rare pathogen Cedecea neteri in a pregnant female with Polyhydramnios: rare case report from UAE. BMC Infect Dis. 2021; 21(1):637. PMC: 8254322. DOI: 10.1186/s12879-021-06298-y. View

13.

Bush K . Past and Present Perspectives on β-Lactamases. Antimicrob Agents Chemother. 2018; 62(10). PMC: 6153792. DOI: 10.1128/AAC.01076-18. View

14.

Thompson J, Higgins D, Gibson T . CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994; 22(22):4673-80. PMC: 308517. DOI: 10.1093/nar/22.22.4673. View

15.

Philippon A, Arlet G, Labia R, Iorga B . Class C β-Lactamases: Molecular Characteristics. Clin Microbiol Rev. 2022; 35(3):e0015021. PMC: 9491196. DOI: 10.1128/cmr.00150-21. View

16.

Kotsakis S, Papagiannitsis C, Tzelepi E, Tzouvelekis L, Miriagou V . Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase. Antimicrob Agents Chemother. 2009; 53(8):3520-3. PMC: 2715598. DOI: 10.1128/AAC.00219-09. View

17.

Papp-Wallace K, Mallo S, Bethel C, Taracila M, Hujer A, Fernandez A . A kinetic analysis of the inhibition of FOX-4 β-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic β-lactams and carbapenems. J Antimicrob Chemother. 2013; 69(3):682-90. PMC: 3922156. DOI: 10.1093/jac/dkt434. View

18.

Chavez Herrera V, Rosas De Silva M, Orendain Alcaraz H, Ceja Espiritu G, Carrazco Pena K, Melnikov V . Death related to Cedecea lapagei in a soft tissue bullae infection: a case report. J Med Case Rep. 2018; 12(1):328. PMC: 6215343. DOI: 10.1186/s13256-018-1866-x. View

19.

Gallagher S, Sasse J . Protein analysis by SDS-PAGE and detection by Coomassie blue or silver staining. Curr Protoc Pharmacol. 2011; Appendix 3:3B. DOI: 10.1002/0471141755.pha03bs02. View

20.

Ammenouche N, Dupont H, Mammeri H . Characterization of a novel AmpC β-lactamase produced by a carbapenem-resistant Cedecea davisae clinical isolate. Antimicrob Agents Chemother. 2014; 58(11):6942-5. PMC: 4249424. DOI: 10.1128/AAC.03237-14. View